MEDI Quote, Financials, Valuation and Earnings

Fidelity Disruptive Medicine ETF has a net margin of -- compared to Harbor Health Care ETF's net margin of --. Harbor Health Care ETF's return on equity of -- beat Fidelity Disruptive Medicine ETF's return on equity of --.

Harbor Health Care ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Fidelity Disruptive Medicine ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Harbor Health Care ETF has higher upside potential than Fidelity Disruptive Medicine ETF, analysts believe Harbor Health Care ETF is more attractive than Fidelity Disruptive Medicine ETF.

Harbor Health Care ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Fidelity Disruptive Medicine ETF has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Harbor Health Care ETF has a quarterly dividend of $0.13 per share corresponding to a yield of 0.4%. Fidelity Disruptive Medicine ETF offers a yield of 0.49% to investors and pays a quarterly dividend of $0.11 per share. Harbor Health Care ETF pays -- of its earnings as a dividend. Fidelity Disruptive Medicine ETF pays out -- of its earnings as a dividend.

Harbor Health Care ETF quarterly revenues are --, which are smaller than Fidelity Disruptive Medicine ETF quarterly revenues of --. Harbor Health Care ETF's net income of -- is lower than Fidelity Disruptive Medicine ETF's net income of --. Notably, Harbor Health Care ETF's price-to-earnings ratio is -- while Fidelity Disruptive Medicine ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Harbor Health Care ETF is -- versus -- for Fidelity Disruptive Medicine ETF. Usually stocks with elevated PS ratios are considered overvalued.

Goldman Sachs Future Health Care Equity ETF has a net margin of -- compared to Harbor Health Care ETF's net margin of --. Harbor Health Care ETF's return on equity of -- beat Goldman Sachs Future Health Care Equity ETF's return on equity of --.

Harbor Health Care ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Goldman Sachs Future Health Care Equity ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Harbor Health Care ETF has higher upside potential than Goldman Sachs Future Health Care Equity ETF, analysts believe Harbor Health Care ETF is more attractive than Goldman Sachs Future Health Care Equity ETF.

Harbor Health Care ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Goldman Sachs Future Health Care Equity ETF has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Harbor Health Care ETF has a quarterly dividend of $0.13 per share corresponding to a yield of 0.4%. Goldman Sachs Future Health Care Equity ETF offers a yield of 0.02% to investors and pays a quarterly dividend of $0.01 per share. Harbor Health Care ETF pays -- of its earnings as a dividend. Goldman Sachs Future Health Care Equity ETF pays out -- of its earnings as a dividend.

Harbor Health Care ETF quarterly revenues are --, which are smaller than Goldman Sachs Future Health Care Equity ETF quarterly revenues of --. Harbor Health Care ETF's net income of -- is lower than Goldman Sachs Future Health Care Equity ETF's net income of --. Notably, Harbor Health Care ETF's price-to-earnings ratio is -- while Goldman Sachs Future Health Care Equity ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Harbor Health Care ETF is -- versus -- for Goldman Sachs Future Health Care Equity ETF. Usually stocks with elevated PS ratios are considered overvalued.

iShares US Medical Devices ETF has a net margin of -- compared to Harbor Health Care ETF's net margin of --. Harbor Health Care ETF's return on equity of -- beat iShares US Medical Devices ETF's return on equity of --.

Harbor Health Care ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand iShares US Medical Devices ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Harbor Health Care ETF has higher upside potential than iShares US Medical Devices ETF, analysts believe Harbor Health Care ETF is more attractive than iShares US Medical Devices ETF.

Harbor Health Care ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison iShares US Medical Devices ETF has a beta of 0.981, suggesting its less volatile than the S&P 500 by 1.854%.

Harbor Health Care ETF has a quarterly dividend of $0.13 per share corresponding to a yield of 0.4%. iShares US Medical Devices ETF offers a yield of 0.47% to investors and pays a quarterly dividend of $0.03 per share. Harbor Health Care ETF pays -- of its earnings as a dividend. iShares US Medical Devices ETF pays out -- of its earnings as a dividend.

Harbor Health Care ETF quarterly revenues are --, which are smaller than iShares US Medical Devices ETF quarterly revenues of --. Harbor Health Care ETF's net income of -- is lower than iShares US Medical Devices ETF's net income of --. Notably, Harbor Health Care ETF's price-to-earnings ratio is -- while iShares US Medical Devices ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Harbor Health Care ETF is -- versus -- for iShares US Medical Devices ETF. Usually stocks with elevated PS ratios are considered overvalued.